Key facts
- This page summarizes Richard H. Scheller's Form 4 filing for BridgeBio Pharma, Inc. (BBIO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Feb 2023, 19:21.
Richard H. Scheller - 16 Feb 2023 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)
- Reporting relationship
- Director
- Issuer ticker
- BBIO
- Reported as of
- 16 Feb 2023
- Net transaction value
- -$16,483
- SEC form
- 4
- Accepted by SEC
- 21 Feb 2023, 19:21:54 UTC
- Prior SEC filing
- 18 Nov 2022
- Next SEC filing
- 09 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian C. Stephenson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Richard H. Scheller filed Form 4 for BridgeBio Pharma, Inc. (BBIO) on 21 Feb 2023.
Change
- Previous filing in this sequence was filed on 18 Nov 2022.
- Current net transaction value: -$16,483.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BBIO
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +3,196
- Change %
- +6.2%
- Price
- Shares after
- 55,126
- Date
- 16 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
BBIO
transaction
Common Stock
Tax liability
- Transaction value
- $16,483
- Shares
- -1,304
- Change %
- -2.4%
- Price
- $12.64
- Shares after
- 53,822
- Date
- 16 Feb 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BBIO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,196
- Change %
- -20%
- Price
- $0.000000
- Shares after
- 12,783
- Date
- 16 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,196
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Richard H. Scheller is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F2
Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 3,196 shares of Common Stock underlying the Reporting Person's RSUs.
Footnote F3
The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.